INAB: IN8bio, Inc. Stock

by  •  • Comments Off on INAB: IN8bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 12.81
Enterprise Value ($M) 0.92
Book Value ($M) 13.88
Book Value / Share 0.17
Price / Book 0.92
NCAV ($M) 6.73
NCAV / Share 0.08
Price / NCAV 1.90

Profitability (mra)
Return on Invested Capital (ROIC) -1.51
Return on Assets (ROA) -1.07
Return on Equity (ROE) -1.56

Liquidity (mrq)
Quick Ratio 4.30
Current Ratio 4.30

Balance Sheet (mrq) ($M)
Current Assets 12.72
Assets 19.87
Liabilities 5.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -29.60
Net Income -30.44

Cash Flow Statement (mra) ($M)
Cash From Operations -24.15
Cash from Investing -0.19
Cash from Financing 14.18

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13D/A BIOS Fund II, LP 9.99 -12.44
02-14 13G/A Ho William Tai-Wei 5.60 31.10
02-14 13G Alyeska Investment Group, L.P. 9.90
01-31 13G/A Hirschman Orin 8.50 -8.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-05-07 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ T
2025-03-13 10-K tm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 107,475 458,082 23.46
2025-05-08 291,861 666,601 43.78
2025-05-07 318,260 636,659 49.99
2025-05-06 338,540 1,158,753 29.22
2025-05-05 84,924 456,387 18.61

(click for more detail)

Similar Companies
IMNM – Immunome, Inc. IMNN – Imunon, Inc.
IMTX – Immatics N.V. INDP – Indaptus Therapeutics, Inc.
INKT – MiNK Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io